These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 28131394

  • 1. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
    Andersson AC, Resende M, Salanti A, Nielsen MA, Holst PJ.
    Vaccine; 2017 Feb 22; 35(8):1140-1147. PubMed ID: 28131394
    [Abstract] [Full Text] [Related]

  • 2. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
    de Moraes LV, Dechavanne S, Sousa PM, Barateiro A, Cunha SF, Nunes-Silva S, Lima FA, Murillo O, Marinho CRF, Gangnard S, Srivastava A, Braks JA, Janse CJ, Gamain B, Franke-Fayard B, Penha-Gonçalves C.
    Infect Immun; 2016 Jun 22; 84(6):1761-1774. PubMed ID: 27045035
    [Abstract] [Full Text] [Related]

  • 3. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
    Gangnard S, Lewit-Bentley A, Dechavanne S, Srivastava A, Amirat F, Bentley GA, Gamain B.
    Sci Rep; 2015 Oct 09; 5():14868. PubMed ID: 26450557
    [Abstract] [Full Text] [Related]

  • 4. A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA.
    Thrane S, Janitzek CM, Agerbæk MØ, Ditlev SB, Resende M, Nielsen MA, Theander TG, Salanti A, Sander AF.
    PLoS One; 2015 Oct 09; 10(11):e0143071. PubMed ID: 26599509
    [Abstract] [Full Text] [Related]

  • 5. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
    Saveria T, Oleinikov AV, Wiliamson K, Chaturvedi R, Lograsso J, Keitany GJ, Fried M, Duffy P.
    Infect Immun; 2013 Apr 09; 81(4):1031-9. PubMed ID: 23319559
    [Abstract] [Full Text] [Related]

  • 6. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
    Pinto VV, Ditlev SB, Jensen KE, Resende M, Dahlbäck M, Andersen G, Andersen P, Theander TG, Salanti A, Nielsen MA.
    PLoS One; 2011 Mar 25; 6(3):e17942. PubMed ID: 21464946
    [Abstract] [Full Text] [Related]

  • 7. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies.
    Bordbar B, Tuikue-Ndam N, Bigey P, Doritchamou J, Scherman D, Deloron P.
    Vaccine; 2012 Feb 08; 30(7):1343-8. PubMed ID: 22226864
    [Abstract] [Full Text] [Related]

  • 8. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
    Gangnard S, Chêne A, Dechavanne S, Srivastava A, Avril M, Smith JD, Gamain B.
    Sci Rep; 2019 Nov 18; 9(1):16978. PubMed ID: 31740695
    [Abstract] [Full Text] [Related]

  • 9. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains.
    Dahlbäck M, Jørgensen LM, Nielsen MA, Clausen TM, Ditlev SB, Resende M, Pinto VV, Arnot DE, Theander TG, Salanti A.
    J Biol Chem; 2011 May 06; 286(18):15908-17. PubMed ID: 21398524
    [Abstract] [Full Text] [Related]

  • 10. Designing a VAR2CSA-based vaccine to prevent placental malaria.
    Fried M, Duffy PE.
    Vaccine; 2015 Dec 22; 33(52):7483-8. PubMed ID: 26469717
    [Abstract] [Full Text] [Related]

  • 11. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
    Doritchamou JYA, Renn JP, Jenkins B, Mahamar A, Dicko A, Fried M, Duffy PE.
    Elife; 2022 Feb 01; 11():. PubMed ID: 35103596
    [Abstract] [Full Text] [Related]

  • 12. Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria.
    Clausen TM, Christoffersen S, Dahlbäck M, Langkilde AE, Jensen KE, Resende M, Agerbæk MØ, Andersen D, Berisha B, Ditlev SB, Pinto VV, Nielsen MA, Theander TG, Larsen S, Salanti A.
    J Biol Chem; 2012 Jul 06; 287(28):23332-45. PubMed ID: 22570492
    [Abstract] [Full Text] [Related]

  • 13. The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine.
    Nielsen MA, Resende M, de Jongh WA, Ditlev SB, Mordmüller B, Houard S, Ndam NT, Agerbæk MØ, Hamborg M, Massougbodji A, Issifou S, Strøbæk A, Poulsen L, Leroy O, Kremsner PG, Chippaux JP, Luty AJ, Deloron P, Theander TG, Dyring C, Salanti A.
    PLoS One; 2015 Jul 06; 10(9):e0135406. PubMed ID: 26327283
    [Abstract] [Full Text] [Related]

  • 14. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site.
    Babakhanyan A, Leke RG, Salanti A, Bobbili N, Gwanmesia P, Leke RJ, Quakyi IA, Chen JJ, Taylor DW.
    PLoS One; 2014 Jul 06; 9(2):e88173. PubMed ID: 24505415
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
    Bir N, Yazdani SS, Avril M, Layez C, Gysin J, Chitnis CE.
    Infect Immun; 2006 Oct 06; 74(10):5955-63. PubMed ID: 16988275
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
    Avril M, Hathaway MJ, Srivastava A, Dechavanne S, Hommel M, Beeson JG, Smith JD, Gamain B.
    PLoS One; 2011 Feb 07; 6(2):e16622. PubMed ID: 21326877
    [Abstract] [Full Text] [Related]

  • 17. Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.
    Barfod L, Dobrilovic T, Magistrado P, Khunrae P, Viwami F, Bruun J, Dahlbäck M, Bernasconi NL, Fried M, John D, Duffy PE, Salanti A, Lanzavecchia A, Lim CT, Ndam NT, Higgins MK, Hviid L.
    J Immunol; 2010 Dec 15; 185(12):7553-61. PubMed ID: 21078904
    [Abstract] [Full Text] [Related]

  • 18. Strain-transcendent immune response to recombinant Var2CSA DBL5-ε domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions.
    Fernandez P, Petres S, Mécheri S, Gysin J, Scherf A.
    PLoS One; 2010 Sep 03; 5(9):e12558. PubMed ID: 20838433
    [Abstract] [Full Text] [Related]

  • 19. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
    Costa FT, Fusaï T, Parzy D, Sterkers Y, Torrentino M, Douki JB, Traoré B, Petres S, Scherf A, Gysin J.
    J Infect Dis; 2003 Jul 01; 188(1):153-64. PubMed ID: 12825185
    [Abstract] [Full Text] [Related]

  • 20. Structural insights into chondroitin sulphate A binding Duffy-binding-like domains from Plasmodium falciparum: implications for intervention strategies against placental malaria.
    Gill J, Chitnis CE, Sharma A.
    Malar J; 2009 Apr 17; 8():67. PubMed ID: 19374733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.